Join
Live feed
·
PRReleasevia Quantisnow
Valneva SE logo

Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World's Most Clinically Advanced Tetravalent Shigella Vaccine Candidate

ByQuantisnow·Wall Street's wire, on your screen.
VALN· Valneva SE
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VALN (Valneva SE) and more on Quantisnow.